Biogen (BIIB) News Today $123.53 +2.60 (+2.15%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$123.57 +0.04 (+0.04%) As of 04:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Biogen (NASDAQ:BIIB) Receives Hold Rating from Needham & Company LLCMay 5 at 4:25 AM | americanbankingnews.comBiogen (NASDAQ:BIIB) Price Target Lowered to $220.00 at Canaccord Genuity GroupMay 5 at 3:43 AM | americanbankingnews.comLeerink Partnrs Estimates Biogen's Q3 Earnings (NASDAQ:BIIB)May 5 at 2:21 AM | americanbankingnews.comBiogen Inc. (NASDAQ:BIIB) Receives Average Rating of "Hold" from AnalystsBiogen Inc. (NASDAQ:BIIB - Get Free Report) has been given an average recommendation of "Hold" by the thirty-two ratings firms that are covering the stock, MarketBeat reports. Twenty investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. ThMay 5 at 2:15 AM | marketbeat.comBiogen (NASDAQ:BIIB) Price Target Lowered to $187.00 at HC WainwrightHC Wainwright lowered their price objective on shares of Biogen from $241.00 to $187.00 and set a "buy" rating for the company in a research report on Friday.May 4 at 10:01 AM | marketbeat.comBiogen (NASDAQ:BIIB) Announces Quarterly Earnings Results, Misses Expectations By $0.24 EPSBiogen (NASDAQ:BIIB - Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported $3.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.26 by ($0.24). Biogen had a return on equity of 14.98% and a net margin of 16.87%. The firm had revenue of $2.43 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the business posted $3.67 EPS. The firm's revenue for the quarter was up 6.2% compared to the same quarter last year.May 4 at 9:18 AM | marketbeat.comRobert W. Baird Cuts Biogen (NASDAQ:BIIB) Price Target to $255.00Robert W. Baird reduced their price objective on Biogen from $300.00 to $255.00 and set an "outperform" rating for the company in a research note on Friday.May 4 at 8:47 AM | marketbeat.comBiogen's (BIIB) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Biogen in a research report on Friday.May 4 at 8:47 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Purchased by Northern Trust CorpNorthern Trust Corp raised its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,550,130 shares of the biotechnology company's stock after aMay 4 at 4:57 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Bought by Integrated Wealth Concepts LLCIntegrated Wealth Concepts LLC grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 185.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,479 shares of the biotechnology company's stock afMay 4 at 4:11 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by MML Investors Services LLCMML Investors Services LLC decreased its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 26.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,515 shares of the biotechnoMay 4 at 3:54 AM | marketbeat.comJune 13th Options Now Available For Biogen (BIIB)May 3 at 10:26 AM | nasdaq.comSchonfeld Strategic Advisors LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB)Schonfeld Strategic Advisors LLC boosted its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 1,002.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 79,516 shares of the biotechnology company's stock after purchasing an additionMay 3 at 5:52 AM | marketbeat.comAQR Capital Management LLC Has $81.91 Million Position in Biogen Inc. (NASDAQ:BIIB)AQR Capital Management LLC boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 982.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 539,692 shares of the biotechnology company's stock after buyingMay 3 at 5:52 AM | marketbeat.comBiogen's results beat estimates on strength in rare disease drugsMay 3 at 2:27 AM | msn.comBiogen (BIIB) Maintains Outperform Rating Despite Lowered Price Target | BIIB Stock NewsMay 2 at 3:59 PM | gurufocus.comLido Advisors LLC Raises Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Lido Advisors LLC grew its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 2,364.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 41,598 shares of the biotechnology company's stock after buyMay 2 at 5:52 AM | marketbeat.comDecoding Biogen Inc (BIIB): A Strategic SWOT InsightMay 2 at 3:30 AM | gurufocus.comPiper Sandler Cuts Biogen (NASDAQ:BIIB) Price Target to $115.00May 2 at 2:49 AM | americanbankingnews.comTruist Financial Cuts Biogen (NASDAQ:BIIB) Price Target to $199.00May 2 at 2:49 AM | americanbankingnews.comBiogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff ImpactMay 1, 2025 | benzinga.comTruist Financial Has Lowered Expectations for Biogen (NASDAQ:BIIB) Stock PriceTruist Financial dropped their price target on shares of Biogen from $210.00 to $199.00 and set a "buy" rating on the stock in a research note on Tuesday.May 1, 2025 | marketbeat.comBiogen Inc. (BIIB) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comBiogen lowers annual earnings outlook, surpasses Q1 estimatesMay 1, 2025 | investing.comBiogen (NASDAQ:BIIB) Beats Q1 Sales TargetsMay 1, 2025 | msn.comPiper Sandler Issues Pessimistic Forecast for Biogen (NASDAQ:BIIB) Stock PricePiper Sandler decreased their target price on Biogen from $135.00 to $115.00 and set a "neutral" rating on the stock in a research report on Tuesday.May 1, 2025 | marketbeat.comBiogen Inc. 2025 Q1 - Results - Earnings Call PresentationMay 1, 2025 | seekingalpha.comPDT Partners LLC Increases Stake in Biogen Inc. (NASDAQ:BIIB)PDT Partners LLC raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 138.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 39,405 shares of the biotechnology company's stock afMay 1, 2025 | marketbeat.comBiogen Inc (BIIB) Q1 2025 Earnings: Revenue Surpasses Estimates at $2. ...May 1, 2025 | gurufocus.comBiogen (BIIB) Surpasses Revenue Expectations in Strong Q1 Performance | BIIB Stock NewsMay 1, 2025 | gurufocus.comBiogen beats quarterly profit estimates on strong demand for rare disease drugsMay 1, 2025 | reuters.comBiogen (NASDAQ:BIIB) Lowered to Hold Rating by Hsbc Global ResHsbc Global Res cut shares of Biogen from a "strong-buy" rating to a "hold" rating in a report on Monday.May 1, 2025 | marketbeat.comVoya Investment Management LLC Sells 3,193 Shares of Biogen Inc. (NASDAQ:BIIB)Voya Investment Management LLC reduced its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,581 shares of theMay 1, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Cut to "Hold" at Hsbc Global ResMay 1, 2025 | americanbankingnews.comBiogen Inc. (NASDAQ:BIIB) is largely controlled by institutional shareholders who own 90% of the companyApril 30, 2025 | finance.yahoo.comBiogen Q1 2025 Earnings PreviewApril 30, 2025 | seekingalpha.comBiogen Earnings: What To Look For From BIIBApril 30, 2025 | msn.comQuarry LP Acquires Shares of 3,005 Biogen Inc. (NASDAQ:BIIB)Quarry LP bought a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,005 shares of the biotechnology company's stock, valued at approximately $460,000. SApril 30, 2025 | marketbeat.comThe Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and RegeneronApril 29, 2025 | theglobeandmail.comWilliam Blair Has Bearish Forecast for Biogen Q2 EarningsApril 29, 2025 | americanbankingnews.comWilliam Blair Estimates Biogen's Q2 Earnings (NASDAQ:BIIB)Biogen Inc. (NASDAQ:BIIB - Free Report) - Stock analysts at William Blair lowered their Q2 2025 earnings per share estimates for shares of Biogen in a research note issued to investors on Wednesday, April 23rd. William Blair analyst M. Minter now forecasts that the biotechnology company will postApril 29, 2025 | marketbeat.comBiogen (BIIB) Expected to Announce Quarterly Earnings on ThursdayApril 29, 2025 | americanbankingnews.comGiant Biogene Announces Annual General Meeting with Key ResolutionsApril 28, 2025 | tipranks.comGiant Biogene Completes Share Placement and Subscription to Fund ExpansionApril 28, 2025 | tipranks.comAquatic Capital Management LLC Has $9.93 Million Holdings in Biogen Inc. (NASDAQ:BIIB)Aquatic Capital Management LLC boosted its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 20.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,945 shares of the biotechnology company's stocApril 28, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Acquired by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD boosted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,933,716 shares of the biotechnolApril 28, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Earns "Hold" Rating from Needham & Company LLCApril 28, 2025 | americanbankingnews.comNeedham & Company LLC Reaffirms Hold Rating for Biogen (NASDAQ:BIIB)Needham & Company LLC reissued a "hold" rating on shares of Biogen in a report on Friday.April 27, 2025 | marketbeat.comWhat is William Blair's Estimate for Biogen FY2027 Earnings?Biogen Inc. (NASDAQ:BIIB - Free Report) - Research analysts at William Blair dropped their FY2027 earnings per share (EPS) estimates for Biogen in a research report issued on Wednesday, April 23rd. William Blair analyst M. Minter now forecasts that the biotechnology company will earn $16.77 per sApril 27, 2025 | marketbeat.comSyon Capital LLC Purchases 2,580 Shares of Biogen Inc. (NASDAQ:BIIB)Syon Capital LLC lifted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 190.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,937 shares of the biotechnology company's stock after buying an adApril 27, 2025 | marketbeat.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.250.73▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼5623▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today United Therapeutics News Today BioMarin Pharmaceutical News Today Incyte News Today Exelixis News Today Neurocrine Biosciences News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
